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ABSTRACT
During RNA interference and related gene regula-
tory pathways, the endonuclease Dicer cleaves pre-
cursor RNA molecules to produce microRNAs
(miRNAs) and short interfering RNAs (siRNAs).
Human cells encode a single Dicer enzyme that
can associate with two different double-stranded
RNA (dsRNA)-binding proteins, protein activator of
PKR (PACT) and trans-activation response RNA-
binding protein (TRBP). However, the functional re-
dundancy or differentiation of PACT and TRBP in
miRNA and siRNA biogenesis is not well under-
stood. Using a reconstituted system, we show
here that PACT and TRBP have distinct effects on
Dicer-mediated dsRNA processing. In particular, we
found that PACT in complex with Dicer inhibits the
processing of pre-siRNA substrates when
compared with Dicer and a Dicer–TRBP complex.
In addition, PACT and TRBP show non-redundant
effects on the production of different-sized
miRNAs (isomiRs), which in turn alter target-
binding specificities. Experiments using chimeric
versions of PACT and TRBP suggest that the two
N-terminal RNA-binding domains of each protein
confer the observed differences in dsRNA substrate
recognition and processing behavior of Dicer–
dsRNA-binding protein complexes. These results
support the conclusion that in humans, Dicer-
associated dsRNA-binding proteins are important
regulatory factors that contribute both substrate
and cleavage specificity during miRNA and siRNA
production.
INTRODUCTION
MicroRNAs (miRNAs) and small interfering RNAs
(siRNAs) are 21–24 nucleotide (nt) non-coding sequences
that regulate gene expression by targeting mRNAs.
During miRNA biogenesis, primary RNA transcripts in
the nucleus are cleaved by the Microprocessor complex to
produce pre-miRNAs that are exported to the cytoplasm.
The endoribonuclease Dicer then catalyzes further
cleavage of these pre-miRNAs to produce mature
miRNAs, which regulate the translation or degradation
of specific mRNAs. Dicer can also generate short
interfering RNAs (siRNAs) by cleaving long double-
stranded RNA (dsRNA) precursors (1,2).
Immunoprecipitation and reconstitution experiments in
various systems have shown that Dicer associates with
proteins in the Argonaute (Ago) family of endonucleases
and with specific double-stranded RNA-binding proteins
(dsRBPs) (3–7). In Drosophila, which encodes two distinct
Dicer isoforms, the Dicer-1 protein binds to the dsRBP
Loquacious (Loqs-PA, PB), which is required for efficient
pre-miRNA cleavage during miRNA biogenesis. Dicer-2,
the other Dicer isoform, binds to Loqs-PD and R2D2,
which contribute to efficient pre-siRNA processing and
siRNA loading onto Ago2 during siRNA biogenesis, re-
spectively (8–12). In organisms including worms and
humans, however, a single Dicer isoform processes both
pre-miRNAs and pre-siRNAs in association with distinct
dsRBP partners. In Caenorhabditis elegans, RDE-4 is the
dsRBP associated to DCR-1 (2,6,7). In humans, these
dsRBPs are protein activator of PKR (PACT) (5) and
trans-activation response RNA-binding protein (TRBP)
(3,4).
In association with Dicer, TRBP contributes to RNA
substrate binding, product length determination and the
assembly of RNA-induced silencing complexes (RISCs)
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(13–15). However, little is known about the function of
PACT, or the underlying mechanisms by which these
dsRBPs influence Dicer-mediated RNA processing. Here
we used an in vitro reconstituted system to investigate the
roles of dsRBPs in different dsRNA substrate processing
reactions. The results of these experiments show that
despite their similar size and three-domain architecture,
TRBP and PACT affect Dicer-catalyzed substrate pro-
cessing differently. TRBP and PACT have distinct
activities both in determining cleavage sites to produce
different sized miRNAs (isomiRs) and in distinguishing
between pre-miRNA and pre-siRNA substrates for
Dicer. In particular, PACT containing Dicer complexes
disfavor pre-siRNA substrates compared with pre-
miRNA substrates much stronger than TRBP containing
Dicer complexes. Using multiple hybrid forms of TRBP-
PACT proteins swapping and deleting domains and/or
linker region, we found that the two N-terminal
dsRNA-binding domains of TRBP and PACT confer
these differential behaviors of Dicer–dsRBP complexes.
These results suggest a model in which TRBP and
PACT function as key regulators of miRNA and siRNA
biogenesis by Dicer in substrate recognition, binding,
processing and RISC loading.
MATERIALS AND METHODS
Expression and purification of proteins and complexes
Dicer, TRBP, Dicer–TRBP and Dicer–TRBP–Ago2
complex were prepared as reported before (15). PACT,
Dicer–PACT and Dicer–PACT–Ago2 were prepared
using the same methods as the complexes containing
TRBP, except a 5ml HiTrap-SP column was used
after TEV cleavage to remove His6-MBP instead of a
Ni-nitrilotriacetic acid column. The bound PACT
protein was eluted from the HiTrap-SP column at
350–400mM KCl during a linear gradient run from
150mM KCl to 1M KCl and subsequently loaded
onto a Superdex-200 gel filtration column. Chimeric
proteins P12T3 and TRBP-PL were expressed and
purified using the same methods as the TRBP purifica-
tion, and PACT-TL was expressed and purified using
same methods as the PACT purification. For the
T12P3 purification, a 5ml HiTrap-Q column was used
before the HiTrap-SP column, and the unbound flow-
through fraction was loaded to 5ml HiTrap-SP column
for the next steps, which were same as the PACT puri-
fication method. Chimeric proteins were designed as
follows: T12P3 has the combined sequence of TRBP
residues 1–232 and PACT residues 197–313. P12T3
has the combined sequence of PACT residues 1–196
and TRBP residues 221–366. TRBP-PL has the
combined sequence of TRBP residues 1–96 and
159–366, connected by PACT linker residues 97–125.
PACT-TL has the combined sequence of PACT
residues 1–96 and 126–313, connected by TRBP linker
residues 93–158. The sequences of the chimeric proteins
are available in the Supporting Information.
RNA substrate preparation
Pre-miRNA substrates were prepared by in vitro transcrip-
tion using T7 RNA polymerase, and the transcribed
RNAs contained one ribozyme at each end for homoge-
neous RNA production. After in vitro transcription,
RNAs were gel purified and end-labeled for use in the
processing assay. For 50 end labelling, RNA was incubated
with T4 polynucleotide kinase (New England Biolabs Inc.)
and [g-32P] ATP for 1 h at 37C. For perfect dsRNA sub-
strates, RNA oligos were ordered from IDT with a 50
phosphate, and gel purified. One strand of each comple-
mentary RNA oligo pair was Calf Intestinal Alkaline
Phosphatase (CIP)-treated before 50 end labelling with
[g-32P] ATP. Equal amounts of each complementary
RNA oligo were incubated at 65C for 10min and slow
cooled to room temperature for annealing. The sequences
of RNA substrates used in this study are as follows: pre-
let-7a, 50-UGAGGUAGUAGGUUGUAUAGUUUUA
GGGUCACACCCACCACUGGGAGAUAACUAUAC
AAUCUACUGUCUUACC-30; pre-miR-200a, 50-AUCU
UACCGGACAGUGCUGGAUUUCCCAGCUUGAC
UCUAACACUGUCUGGUAACGAUGU-30; pre-miR-
34c, 50-AGGCAGTGTAGTTAGCTGATTGCTAATA
GTACCAATCACTAACCACACGGCCAGG-30; dsRNA
W1, 30-UUACCGGAACCCGUUGCCAUUAAGCCCU
AAUGGCUCUGGC-50-Biotin, 50-UGGCCUUGGGCA
ACGGUAAUUCGGGAUUACCGAGACCG-30;
dsRNA W2, 30-UUAAUGGCAACGGGUUCCGGUAA
GCCCUAAUGGCUCUGGC-50-Biotin, 50-UUACCGUU
GCCCAAGGCCAUUCGGGAUUACCGAGACCG-30.
Kinetic assays
Labeled RNA substrates were processed with the
indicated amount of Dicer or Dicer–dsRBP complexes in
dicing buffer [20mM Tris–HCl (pH 6.5), 1.5mMMgCl2,
25mMNaCl, 1mM dithiothreitol and 1% glycerol]. Each
time point sample was prepared by being quenched with
1.2 volumes of loading buffer (95% formamide, 18mM
ethylenediaminetetraacetic acid, 0.025% sodium dodecyl
sulphate, 0.1% xylene cyanol and 0.1% bromophenol
blue). Samples were heated at 70C for 10min before
loading on a 12–15% denaturing 7M urea polyacrylamide
gel electrophoresis. The gels were dried and the amount of
pre-miRNA and pre-siRNA substrates and miRNA and
siRNA products were quantified with a phosphorimager
(GE Healthcare).
RESULTS
Both TRBP and PACT form stable complexes with Dicer
TRBP and PACT share similar architectures consisting of
three dsRNA-binding domains (dsRBDs) (Figure 1A and
Supplementary Figure S1), and the corresponding domains
of TRBP and PACT have high sequence similarities (50–
60% identity in Table 1). Both TRBP and PACT bind to
Dicer using their C-terminal dsRBD (dsRBD3), while the
two N-terminal dsRBDs (dsRBD1-2) are responsible for
dsRNA binding (5,16,17). Although TRBP forms a stable
Dicer–TRBP complex that has increased RNA-binding
Nucleic Acids Research, 2013, Vol. 41, No. 13 6569
affinity relative to Dicer alone (14), the stability and con-
sequences of PACT association with Dicer have not been
clear. We tested whether PACT forms a stable complex
with Dicer and also whether it changes Dicer’s affinity for
dsRNA substrates. Gel filtration column chromatography
and electrophoretic mobility shift assay results show that
PACT associates stably with Dicer to make a Dicer–PACT
complex, which increase the RNA-binding affinity of Dicer
(Supplementary Figures S2–S3 and Figure1B). While both
TRBP and PACT increase Dicer’s dsRNA-binding affinity,
PACT has a lower affinity for dsRNA than TRBP does as
the amount of dsRNA being shifted by PACT is less
than that of TRBP in the same condition. Still, PACT
did not dissociate from the Dicer–PACT complex as the
observed RNA bands shifted by Dicer–PACT binding
(Figure1B, right panel, lane 7–9) were distinct from the
RNA band shifted by PACT binding (Figure1B, right
panel, lane 1–3). In addition, PACT forms a stable tripar-
tite complex with Dicer and Ago2 similar to TRBP (18).
Non-redundant effects of TRBP and PACT on
Dicer processing
TRBP stimulates pre-miRNA and pre-siRNA processing
by increasing substrate affinity to Dicer (14). In addition,
TRBP affects miRNA processing by altering both sub-
strate specificity and product length (12,13). By contrast,
Figure 1. TRBP and PACT increase RNA binding of Dicer as a complex with Dicer. (A) Domain architectures of TRBP and PACT. Each consists
of three dsRNA-binding domains. (B) dsRNA binding by dsRBPs and the Dicer–dsRBP heterodimers. Dicer alone does not bind to the dsRNA, but
Dicer–dsRBP complexes bind to dsRNA. The gel shifts by Dicer–dsRBP complexes and by each dsRBP were distinct showing that dsRBPs help
Dicer binding to dsRNA as Dicer–dsRBP complexes. dsRNA A (0.5 mM) and 0, 0.5 or 1 mM protein/complex in 20 ml of binding buffer [20 mM
HEPES (pH 7.5), 300mM KCl, 5% glycerol, 1mM TCEP] were incubated on ice for 45min before loading to 6% Native PAGE. The gel was stained
with SYBR-Gold.
Table 1. Sequence comparison between dsRBDs of TRBP and PACT
TRBP
domain 1
TRBP
domain 2
TRBP
domain 3
PACT domain 1 56 (73) 36 (42) NS
PACT domain 2 40 (49) 63 (79) NS
PACT domain 3 33 (35) NS 53 (75)
The first number in the cell represents the Identity (%) and the number
in parenthesis represents the Similarity/Positives (%). NS means no
significant similarity. Bold values indicate high sequence similarity
between corresponding domains of TRBP and PACT.
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Figure 2. TRBP and PACT affect pre-miRNA and pre-siRNA processing by Dicer in non-redundant fashion. (A) Dicer–TRBP (D/T) and Dicer–
PACT (D/P) are not redundant in producing different-sized miRNAs in pre-miR-200a and pre-miR-34c processing. Assays were done in a single
turnover condition with 10-fold excess amount of protein/complex to RNA. RNA substrates were labeled by 32P phosphate at 50 end, which is
marked with an asterisk. [RNA]=5nM and [Dicer]/[Dicer–TRBP]/[Dicer–PACT]=50nM were incubated in reaction buffer for 60min (see
‘Materials and Methods’ section) and quenched with 1.2 volumes of 2-fold formamide dye. Samples were boiled at 70C for 10min before
loading to 12% denaturing PAGE. After drying, the gel was exposed to a phosphoscreen. (B) Dicer–PACT processes pre-siRNA (dsRNA W1)
much less efficiently than Dicer and Dicer–TRBP in a single turnover condition with 10-fold excess amount of protein/complex to RNA. dsRNA W1
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(continued)
the function of PACT in Dicer processing is unclear. To
test the effects of PACT on Dicer-catalyzed RNA process-
ing compared with TRBP, we tested various substrates for
the processing by Dicer–dsRBP complexes, including the
natural pre-miRNAs pre-let-7a, pre-miR-34c and pre-
miR-200a, and synthetic pre-siRNAs, dsRNA W1 and
dsRNA W2, consisting of 35 perfect base pairs with
30 two-nucleotide single-stranded overhangs on one end
(Figure 2).
The results showed that TRBP and PACT have different
effects on both miRNA and siRNA processing. We found
that both Dicer–TRBP and Dicer–PACT complexes
process pre-miRNAs (pre-let-7a, pre-miR-34c) efficiently,
but these complexes do not produce the same miRNA
products in processing pre-miR-200a and pre-miR-34c
(Figure 2). Dicer–TRBP produces two miRNAs and
Dicer–PACT produces only one miRNA from pre-miR-
200a, while Dicer–TRBP produces one miRNA and
Dicer–PACT produces two miRNAs for pre-miR-34c
(Figure 2A). This suggests that PACT does not affect the
activity of Dicer in isomiR production at least for the two
substrates tested. For pre-siRNA processing, we found that
Dicer–PACT processes pre-siRNA substrates (dsRNA W1
and W2) much less efficiently than Dicer or Dicer–TRBP
(Figure 2B and C). These results could not be explained by
an overall low activity of Dicer–PACT as the same complex
rapidly processes pre-let-7a and pre-miR-34c. Nor could
these results be explained by dissociation of PACT from
Dicer–PACT complex, as PACT domain 1–2 (P12), con-
taining dsRNA-binding domains and lacking the Dicer
interacting domain, shows faster pre-siRNA processing
than the Dicer–PACT complex when added to Dicer pro-
cessing reaction (Dicer:P12=1:1 ratio) (Supplementary
Figures S4 and S5). This finding suggests that the inhibitory
effect of Dicer–PACT in pre-siRNA processing does not
result from the segregation of dsRNA substrates by free
PACT or P12. The binding affinity does not explain the
inhibitory effect of PACT in siRNA processing compared
with Dicer either, as Dicer–PACT still binds tighter to
dsRNA than does Dicer alone (Figure 1B). Furthermore,
the assays were performed under single turnover conditions
using a 10-fold molar excess of Dicer/Dicer–dsRBP
complexes relative to RNA substrates. Thus, these results
support the conclusion that Dicer–PACT has different sub-
strate specificity compared with Dicer and Dicer–TRBP,
with greatly reduced cleavage activity with pre-siRNAs,
contingent on the tethering of PACT to Dicer.
Differential effects of TRBP and PACT in complexes
containing Ago2
In humans, TRBP, as one of the core components of
RISC loading complex, helps assemble mature miRNAs
or siRNAs into complexes containing Dicer, TRBP and
Argonaute 2 (Ago2) and enhances the stability of the
resulting assembly (3,4,15,19). As described above, we
found that PACT also associates with Dicer and Ago2
to form a stable tripartite complex (18). While
pre-associated Dicer–Ago2–TRBP complexes are
thought to generate mature miRNAs in vivo (20–22),
little is known about Dicer–PACT–Ago2 complexes. To
test small RNA processing by such PACT-containing
complexes, we tested the substrates described above for
cleavage rates (pre-let-7a, pre-miR-34c and dsRNA W1)
and product length specificity (pre-miR-200a and pre-
miR-34c). The results of these experiments showed that
Dicer–Ago2–TRBP and Dicer–Ago2–PACT produce the
same miRNA products from pre-miR-200a and pre-miR-
34c substrates as observed for Dicer–TRBP and Dicer–
PACT, respectively (Figure 3A). In addition, both
Dicer–Ago2–PACT and Dicer–Ago2–TRBP catalyze
pre-let-7a and pre-miR-34c processing with similar effi-
ciency. However, Dicer–Ago2–PACT processes pre-
siRNAs with lower efficiency than Dicer–Ago2–TRBP
does. These data support the conclusion that like Dicer–
PACT, Dicer–Ago2–PACT also disfavors pre-siRNA pro-
cessing compared with pre-miRNA processing (Figure
3B). These results demonstrate that Dicer–Ago2–TRBP
and Dicer–Ago2–PACT retain the substrate specificity
and product identities of Dicer–TRBP and Dicer–PACT,
respectively, suggesting that dsRBPs also affect
dsRNA processing in the context of Ago-containing
complexes.
N-terminal dsRNA-binding domains confer differential
effects of dsRBPs on Dicer
Our results show that TRBP and PACT affect Dicer pro-
cessing by altering both substrate specificity as well as
product length. These differences could result from differ-
ent scenarios: One possibility is that the dsRBDs of TRBP
and PACT interact with RNA substrates to influence their
structures and relative orientation on Dicer affecting pro-
cessing rates and cleavage sites. Alternatively, the inter-
action between TRBP or PACT and the Dicer helicase
domain could induce different conformational changes
in Dicer that affect Dicer processing.
As mentioned earlier, both TRBP and PACT interact
with Dicer using their C-terminal dsRBD3 and bind to
dsRNA substrates with the two N-terminal dsRBD1-2
(5,16,17,23). To investigate the mechanism of dsRBPs’
effects on Dicer, we designed two chimeric proteins,
T12P3 and P12T3, in which the third domain of TRBP
and PACT has been swapped (Figure 4A). These chimeric
proteins separate the two N-terminal dsRBD1-2
Figure 2. Continued
was labeled with 32P phosphate at 50 end of the bottom strand, which is marked with asterisk. [RNA]=5nM and [Dicer]/[Dicer–TRBP]/[Dicer–
PACT]=50nM were incubated in reaction buffer. The reactions were quenched at each time point and the following steps were the same as
described in (A). (C) Dicer, Dicer–TRBP and Dicer–PACT processing kinetics for pre-miRNAs (pre-let-7a and pre-miR-34c) and pre-siRNAs
(dsRNA W1 and dsRNA W2). Dicer–PACT processes pre-siRNA much slower than Dicer and Dicer–TRBP, while processing pre-let-7a and
pre-miR-34c as efficiently as Dicer and Dicer–TRBP. A single turnover reaction condition with 10-fold excess amount of protein/complex to
RNA was used for kinetic assays as in (A). The quenched samples were boiled and loaded onto 12% denaturing gel. After drying and exposing
the gel to phosphoscreen, precursor substrate and product miRNA or siRNA bands were quantified by ImageQuant software (GE Healthcare life
sciences). % Cleavage was calculated by 100 (product miRNA counts)/(total counts  sum of substrate and product RNA counts).
6572 Nucleic Acids Research, 2013, Vol. 41, No. 13
Figure 3. TRBP and PACT retain their effects on pre-miRNA and pre-siRNA processing by Dicer in Ago2 containing complexes: Dicer–Ago2–
TRBP and Dicer–Ago2–PACT. (A) Dicer–Ago2–TRBP (D/A/T) and Dicer–Ago2–PACT (D/A/P) produce the same species of product miRNAs
when processing pre-miR-200a and pre-miR-34c as Dicer–TRBP (D/T) and Dicer–PACT (D/P), respectively. Assays were done in a single turnover
condition with 10-fold excess amount of protein/complex. [RNA]=5nM and [D/A/T] or [D/A/P]=50 nM were incubated in the reaction buffer and
the reaction was quenched after 60min by adding 1.2 volume of 2-fold formamide dye. The following steps were the same as described in Figure 2A.
(B) Dicer–Ago2–PACT (D/A/P) shows extremely low efficiency in pre-siRNA processing compared with Dicer–Ago2–TRBP (D/A/T) while pro-
cessing pre-let-7a and pre-miR-34c are as fast as Dicer–Ago2–TRBP (D/A/T) as shown in Dicer–PACT and Dicer–TRBP in Figure 2B. For dsRNA
W1 processing gel, each reaction has been quenched at the indicated time point and the following steps were the same as described in Figure 2B. For
kinetic graphs, pre-let-7a, pre-miR-34c and dsRNA W1 were processed by Dicer–Ago2–PACT (D/A/P) and Dicer–Ago2–TRBP (D/A/T) in a single
turnover condition with 10-fold excess amount of protein complex as in (A). The following steps were the same as described in Figure 2C.
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responsible for dsRNA binding from the third domain
responsible for the interaction with Dicer so that we are
able to track where the differential effect of the dsRBPs
come from. These proteins were prepared as complexes
with Dicer (Supplementary Figures S2 and S3) and
tested for pre-miRNA and pre-siRNA processing. We
found that the Dicer–T12P3 complex produces the
same two miRNA products as observed for the Dicer–
TRBP complex for pre-miR-200a processing (Figure 4B).
Likewise, the Dicer–P12T3 complex showed results
similar to those obtained with Dicer–PACT for pre-
miR-200a processing producing a single miRNA
product. In addition, the Dicer–P12T3 complex showed
low efficiency in processing pre-siRNA dsRNA W1
(Figure 4B) similar to Dicer–PACT complex. It is note-
worthy that P12T3 has the third domain from TRBP,
and the interaction between Dicer and P12T3 should
be as strong as the interaction between Dicer and
TRBP. This result shows that the region containing
two N-terminal dsRBDs of TRBP and PACT is
enough to induce the effect of full-length TRBP and
PACT in small RNA processing (T1-TL-T2 and P1-PL-
P2, respectively in Figure 4A). In addition, there appears
to be little difference in activities mediated by the
C-terminal dsRBDs of TRBP and PACT in the Dicer–
dsRBP complexes.
To narrow down the functional regions responsible
for the differential effects of TRBP and PACT, we
prepared linker-swapped proteins, TRBP-PL and
PACT-TL, in which the linker region between the two
N-terminal dsRBDs in TRBP and PACT (TL and PL)
was switched (Figure 4A and Supplementary Figure S1).
We found that Dicer–TRBP-PL produces 5-fold more
1-nt longer miRNA (isomiR) than Dicer–PACT-TL in
pre-miR-200a processing (Figure 4C). In addition,
Dicer–PACT-TL shows much less efficient pre-siRNA
processing activities than Dicer–TRBP-PL, similar
to Dicer–PACT and Dicer–TRBP, respectively
(Figure 4D). These results suggest that the differential
effects of dsRBPs on Dicer arise largely from the two
N-terminal dsRBDs, dsRBD1 and dsRBD2, of TRBP
and PACT.
Figure 4. Mechanistic studies of the effects of dsRBPs on Dicer by swapping domain and linker between TRBP and PACT. (A) Construct design for
TRBP and PACT chimeric proteins swapping the third domain (T12P3 and P12T3) and linker region between domain 1 and domain 2 (TRBP-PL
and PACT-TL). (B) Dicer–T12P3 (D-T12P3) and Dicer–P12T3 (D-P12T3) produce highly similar product miRNAs as Dicer–TRBP (D/T) and
Dicer–PACT (D/P), respectively, in processing pre-miR-200a. Dicer–P12T3 processes pre-siRNA (dsRNA W1) much less efficiently than Dicer and
Dicer–TRBP as in Figure 2C, which mimics Dicer–PACT processing (Figure 2C). For pre-miR-200a processing gel, each reaction has been quenched
after 60min by adding 1.2 volume of 2-fold formamide dye. The following steps were as same as in Figures 2A and 3A. For kinetic graphs,
pre-let-7a, pre-miR-34c and dsRNA W1 were processed by Dicer–P12T3 in a single turnover condition with 10-fold excess amount of protein
complex. [RNA]=5nM and [Dicer–P12T3]=50 nM were incubated in the reaction buffer and the reaction was quenched at each time point by
adding 1.2 volume of 2-fold formamide dye. The following steps were the same as described in Figures 2C and 3B. (C) Dicer–TRBP-PL and Dicer–
PACT-TL process pre-miR-200a producing similar isomiR products to Dicer–TRBP and Dicer–PACT, respectively. Bar graphs show relative isomiR
(1nt longer miR)/miR ratio in pre-miR-200a processing by Dicer–dsRBPs (Dicer–TRBP and Dicer–PACT) and Dicer-chimeric dsRBPs (Dicer–
T12P3, Dicer–P12T3, Dicer–TRBP-PL and Dicer–PACT-TL). Error bar represents Standard Deviation (SD). (D) Dicer–PACT-TL processes pre-
siRNA (dsRNA W1) much less efficiently than Dicer–TRBP-PL, while both Dicer–PACT-TL and Dicer–TRBP-PL processes pre-let-7a and pre-miR-
34c efficiently. pre-let-7a, pre-miR-34c and dsRNA W1 were processed by Dicer–PACT-TL and Dicer–TRBP-PL in a single turnover condition with
10-fold excess amount of protein complex. [RNA]=5nM and [Dicer–TRBP-PL]/ [Dicer–PACT-TL]=50 nM were incubated in the reaction buffer
and the reaction was quenched at each time point by adding 1.2 volume of 2-fold formamide dye. The following steps were the same as described in
Figures 2C and 3B.
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DISCUSSION
Double-stranded RNA-binding proteins contribute to
RNAi and related pathways in eukaryotic organisms
including humans, Drosophila and C.elegans. We found
that the human dsRBPs TRBP and PACT, which bind
directly to Dicer, alter both the kinetics and substrate
specificity of Dicer-mediated RNA processing. To our
surprise, PACT and TRBP work in a non-redundant
fashion in small RNA biogenesis: PACT in
complex with Dicer does not induce the same isomiRNA
production as those observed with TRBP in pre-miRNA
processing. In addition, PACT inhibits pre-siRNA pro-
cessing by Dicer in Dicer–PACT complex (Figure 2)
when compared with the cleavage of Dicer–TRBP and
Dicer.
The differential effects of TRBP and PACT on Dicer
imply that Dicer’s activity can be modulated depending on
its binding partner proteins, and that TRBP and PACT
are important regulatory factors for miRNA and siRNA
processing. Interestingly, we observed that these differen-
tial effects of PACT and TRBP on Dicer-catalyzed RNA
processing also hold true in the context of Ago2-contain-
ing complexes (Figure 3). Overall, these results suggest
that these human dsRBPs play important roles in RNAi
during initial substrate recognition, Dicer processing and
possibly RISC loading.
While the previous publications (5,24) suggested Dicer,
TRBP and PACT could associate to ternary complexes, it
has been shown that either TRBP or PACT could be the
dsRBP directly interacting with Dicer in Dicer–TRBP–
PACT ternary complexes (24). So investigation of the
functional effects of TRBP and PACT when in direct
contact with Dicer would be important to understand
the regulatory mechanisms of small RNA biogenesis in
humans.
Our results show that the first two N-terminal dsRBDs
(dsRBD1 and 2) are the key domains for determining the
differential effects of PACT and TRBP on Dicer–dsRBP
complexes. Interestingly, when we tested truncated TRBP
and PACT with only two N-terminal domain dsRBD1-2
(T12 and P12, respectively) with equivalent amount of
Dicer for pre-miR-200a and dsRNA W1 processing, T12
and P12 were not sufficient to confer the same effects on
Dicer-catalyzed RNA processing as observed for the full-
length proteins (Supplementary Figure S4). As dsRBD3 is
lacking, T12 and P12 do not bind directly to Dicer. This
result implies that physical tethering of PACT or TRBP to
Dicer influences the effects of their RNA-binding domains
on RNA recruitment, relative orientation or induced con-
formational changes. These findings support a model in
which PACT and TRBP docking on Dicer’s helicase
domain recruit dsRNA substrates to Dicer and remain
associated with these substrates to affect their structure
and relative positioning on Dicer’s active site (Figure 5).
It is possible that PACT and TRBP binding to dsRNA
substrates may also influence the following steps, product
release and loading of the resulting miRNAs or siRNAs
into Ago2, by retaining their interaction with product
dsRNAs after cleavage.
It is possible that Dicer forms complexes with either
PACT or TRBP under different conditions or in different
cell types, and that these complexes in turn modulate
Dicer’s activity for pre-miRNA and pre-siRNA process-
ing. The regulation of TRBP and PACT in miRNA and
siRNA biogenesis could be complicated in vivo. The regu-
lation of their relative expression levels and their localiza-
tion has not been clear yet. In addition, there are TRBP
and PACT interacting proteins such as PKR and Merlin
(16,25–28) and posttranslational modifications of TRBP
and PACT, which potentially alter the availability of
TRBP and PACT for Dicer (19,29).
Both TRBP and PACT bind to the interferon-induced
dsRNA-regulated protein kinase PKR, which binds to
dsRNA and is involved in the host inflammatory
response. Interestingly, TRBP is an inhibitor, whereas
PACT is an activator of PKR (25–28). The interactions
of TRBP and PACT with PKR are distinct from their
interactions with Dicer, as the two N-terminal dsRBDs
of each protein are essential for PKR binding, while the
third domain is responsible for PKR regulation in each
case (25). It is not known whether or how TRBP and
PACT provide crosstalk between RNAi and PKR
pathways. As both RNAi and PKR pathways have a
role in antiviral responses, it would be interesting to
understand how human dsRBPs TRBP and PACT affect
RNAi and other defense pathways in normal and virus-
infected cells in the future.
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Figure 5. A mechanistic model showing how TRBP and PACT differ-
entiate Dicer processing. The two N-terminal dsRBDs of TRBP and
PACT bind to dsRNA substrates and recruit them to Dicer–dsRBP
complexes, where cleavage occurs with dsRBPs bound to the dsRNA
substrates. The two N-terminal dsRBDs of TRBP and PACT affect
dsRNA structure and orientation on Dicer differently, altering Dicer
processing.
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